110 related articles for article (PubMed ID: 1519481)
1. Systemic interferon-alpha in the treatment of HTLV-I-associated myelopathy.
Kuroda Y; Kurohara K; Fujiyama F; Takashima H; Endo C; Matsui M; Neshige R; Kakigi R
Acta Neurol Scand; 1992 Jul; 86(1):82-6. PubMed ID: 1519481
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of HTLV-I-associated myelopathy with alpha-interferon and high-dose of gamma-globulin].
Kuroda Y; Takashima H; Endo C; Neshige R; Kakigi R
Rinsho Shinkeigaku; 1990 Jun; 30(6):594-8. PubMed ID: 1699697
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha treatment in HTLV-I-associated myelopathy. Studies of clinical and immunological aspects.
Shibayama K; Nakamura T; Nagasato K; Shirabe S; Tsujihata M; Nagataki S
J Neurol Sci; 1991 Dec; 106(2):186-92. PubMed ID: 1802967
[TBL] [Abstract][Full Text] [Related]
4. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
[TBL] [Abstract][Full Text] [Related]
5. Long-term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy/tropical spastic paraparesis: a combined clinical, virological and immunological study.
Yamasaki K; Kira J; Koyanagi Y; Kawano Y; Miyano-Kurosaki N; Nakamura M; Baba E; Suzuki J; Yamamoto A; Yamamoto N; Kobayashi T
J Neurol Sci; 1997 Apr; 147(2):135-44. PubMed ID: 9106118
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial.
Izumo S; Goto I; Itoyama Y; Okajima T; Watanabe S; Kuroda Y; Araki S; Mori M; Nagataki S; Matsukura S; Akamine T; Nakagawa M; Yamamoto I; Osame M
Neurology; 1996 Apr; 46(4):1016-21. PubMed ID: 8780082
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
[TBL] [Abstract][Full Text] [Related]
8. The impact of interferon-alpha treatment on clinical and immunovirological aspects of HTLV-1-associated myelopathy in northeast of Iran.
Rafatpanah H; Rezaee A; Etemadi MM; Hosseini RF; Khorram B; Afsahr L; Taylor G; Mokhber N; Mahmoudi M; Abbaszadegan MR; Foroghipor M; Hashemi P; Amiri A; Tehrani M; Azarpazhooh A; Azarpazhooh MR
J Neuroimmunol; 2012 Sep; 250(1-2):87-93. PubMed ID: 22727800
[TBL] [Abstract][Full Text] [Related]
9. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
10. Blockade of IL-2 receptor suppresses HTLV-I and IFN-gamma expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Fukushima N; Nishiura Y; Nakamura T; Kohno S; Eguchi K
Intern Med; 2007; 46(7):347-51. PubMed ID: 17409595
[TBL] [Abstract][Full Text] [Related]
11. Human T lymphotropic virus type I associated myelopathy and myasthenia gravis: a possible association?
Fukui T; Sugita K; Ichikawa H; Negishi A; Kasai H; Tsukagoshi H
Eur Neurol; 1994; 34(3):158-61. PubMed ID: 8033942
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
13. CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha.
Narikawa K; Fujihara K; Misu T; Feng J; Fujimori J; Nakashima I; Miyazawa I; Saito H; Sato S; Itoyama Y
J Neuroimmunol; 2005 Feb; 159(1-2):177-82. PubMed ID: 15652417
[TBL] [Abstract][Full Text] [Related]
14. Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load.
Kira J; Nakamura M; Sawada T; Koyanagi Y; Ohori N; Itoyama Y; Yamamoto N; Sakaki Y; Goto I
J Neurol Sci; 1992 Jan; 107(1):98-104. PubMed ID: 1578240
[TBL] [Abstract][Full Text] [Related]
15. [HTLV-I-associated myelopathy].
Osame M
Nihon Naika Gakkai Zasshi; 1992 Mar; 81(3):389-92. PubMed ID: 1607802
[No Abstract] [Full Text] [Related]
16. Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1.
Santos SB; Porto AF; Muniz AL; Luna T; Nascimento MC; Guerreiro JB; Oliveira-Filho J; Morgan DJ; Carvalho EM
Neuroimmunomodulation; 2006; 13(3):145-51. PubMed ID: 17119343
[TBL] [Abstract][Full Text] [Related]
17. [The clinical features of HTLV-I infection. HTLV-I associated myelopathy].
Nakagawa M; Izumo S; Ikurou M; Osame M
Uirusu; 1992 Jun; 42(1):21-8. PubMed ID: 1413532
[No Abstract] [Full Text] [Related]
18. Exaggerated messenger RNA expression of inflammatory cytokines in human T-cell lymphotropic virus type I-associated myelopathy.
Watanabe H; Nakamura T; Nagasato K; Shirabe S; Ohishi K; Ichinose K; Nishiura Y; Chiyoda S; Tsujihata M; Nagataki S
Arch Neurol; 1995 Mar; 52(3):276-80. PubMed ID: 7872881
[TBL] [Abstract][Full Text] [Related]
19. Presence of human T lymphotropic virus type I in two patients with progressive myelopathy in Puerto Rico.
Reyes-Iglesias Y; Melendez-Feliciano R; Garayalde-Cotroneo G
Neurology; 1991 Sep; 41(9):1515-6. PubMed ID: 1891106
[TBL] [Abstract][Full Text] [Related]
20. Human T-lymphotropic virus type I (HTLV-I)-specific antibodies and cell-free RNA in crevicular fluid-rich saliva from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy.
Soto-Ramirez LE; Garcia-Vallejo F; Renjifo B; Vergara A; Borrero I; Marlink R; Essex M
Viral Immunol; 1995; 8(3):141-50. PubMed ID: 8833267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
